Eris Lifesciences Ltd.
Snapshot View

685.00 -8.45 ▼-1.2%

26 September 2022, 04:01:00 PM
Volume: 2,380

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.eris.co.in
Market Cap 9,403.76 Cr.
Enterprise Value(EV) 9,397.80 Cr. 2022-03
Financial Indicators
Earnings per share (EPS) 28.97 Trailing Twelve Months Ending 2022-06
Price-Earning Ratio (PE) 23.64 Trailing Twelve Months Ending 2022-06
Industry PE 30.55 Trailing Twelve Months Ending 2022-06
Book Value / Share 147.08 Trailing Twelve Months Ending 2022-06
Price to Book Value 4.66 Calculated using Price: 685.00
Dividend Yield 0.87 Period Ending 2022-03
No. of Shares Subscribed 13.60 Cr. 135,990,717 Shares
FaceValue 1
Company Profile
The company develops, manufactures and commercializes branded pharmaceutical products in select therapeutic areas within the chronic and acute categories of the IPM, such as: cardiovascular; anti-diabetics; vitamins; gastroenterology; and anti-infectives. Its focus has been on developing products in the chronic and acute category which are linked to lifestyle related disorders.

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
-1.22%
1 Week
-0.77%
1 Month
-0.52%
3 Month
+4.43%
6 Month
-3.56%
1 Year
-7.02%
2 Year
+26.64%
5 Year
+20.79%
10 Year
9 years 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) 50.12 40.30 47.68 56.90 41.30 28.96 24.28 24.78 23.33
Return on Capital Employed (%) 68.93 49.25 54.56 62.56 35.76 26.54 25.44 27.60 25.29
Return on Assets (%) 32.09 28.59 36.17 43.89 27.31 20.02 20.33 22.62 21.27

Balance Sheet View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Shh. Funds 106 177 266 300 567 861 1,151 1,296 1,576 1,908
Non Curr. Liab. 17 18 19 20 12 248 -66 -80 -109 -79
Curr. Liab. 44 71 65 69 129 294 377 220 235 283
Minority Int. 5 4 4 3 24 25 18 0
Equity & Liab. 172 270 354 392 732 1,428 1,481 1,437 1,703 2,113
Non Curr. Assets 45 115 191 169 463 1,061 827 902 1,167 1,402
Curr. Assets 126 155 163 222 270 367 653 535 536 711
Misc. Exp. not W/O
Total Assets 172 270 354 392 732 1,428 1,481 1,437 1,703 2,113

Profit Loss View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-06 Rs. Cr. TTM
Net Sales 509 546 597 750 856 982 1,074 1,212 1,347 1,396
Other Income 4 3 3 25 26 32 16 9 26 23
Total Income 513 549 600 775 882 1,014 1,090 1,221 1,373 1,419
Total Expenditure -410 -424 -425 -480 -533 -637 -706 -781 -862 -909
PBIDT 103 125 175 294 349 377 384 439 511 511
Interest 0 0 0 -1 -11 -23 -2 -2 -4 -11
Depreciation -5 -16 -20 -23 -26 -36 -50 -43 -65 -74
Taxation -27 -20 -20 -24 -17 -26 -35 -39 -36 -34
Exceptional Items
PAT 71 89 135 247 295 291 297 355 406 392
Minority Interest 0 0 -1 0 -1 0 0 0 2
Share Associate
Other Related Items
Consolidated Net Profit 71 89 134 247 294 291 297 355 406 394
Adjusted EPS 5,130 6,466 9,679 18 21 21 22 26 30 29

Cash Flow View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. 38 90 90 131 200 235 223 271 375 378
Cash Fr. Inv. -36 -83 -92 -44 -184 -590 -5 123 -323 -320
Cash Fr. Finan. -3 -2 0 -84 -24 363 -221 -335 -82 -45
Net Change -1 5 -2 4 -8 8 -3 60 -30 14
Cash & Cash Eqvt 2 7 5 9 2 11 8 67 37 51

Shareholding Pattern View Details >>

9 Qtrs 2020-06 (%) 2020-09 (%) 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%)
Promoter 55.55 54.08 54.23 54.13 52.69 52.68 52.66 52.66 52.30
Public 44.45 45.92 45.77 45.87 47.31 47.32 47.34 47.34 47.70
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Announcements View Details >>

Sat, 24 Sep 2022
INTIMATION OF RECEIPT OF REQUEST FOR RE-CLASSIFICATION FROM 'PROMOTER GROUP' TO 'PUBLIC' CATEGORY UNDER REGULATION 30 AND 31A OF SEBI (LISTING OBLIGATIONS DISCLOSURE REQUIREMENTS) REGULATIONS 2015 ('LISTING REGULATIONS')
Dear Sir/Madam The Company has received today the attached request letter dated 19th September 2022 from Shah & Co. constituent of Promoter Group of Mr. Kaushal Shah Promoter of the Company seeking a reclassification from Promoter Group to Pubic category for the reasons appearing therein.The request will be considered by the Board of Directors of the Company and all appropriate approvals will be sought by the Company as set out in Regulation 31A of Listing Regulations.Thanking You
Mon, 19 Sep 2022
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
INTIMATION OF SCHEDULE OF ANALYST / INSTITUTIONAL INVESTOR MEETINGS
Fri, 09 Sep 2022
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS
Allotment of equity shares pursuant to ESOP-2017 Scheme

Technical Scans View Details >>

Mon, 26 Sep 2022
Closing Near 50 SMA Closing Near 50 SMA
Closing Near 200 SMA Closing Near 200 SMA
Close Crossing 200 SMA From Above Close Crossing 200 SMA From Above
Closing Near 20 SMA Closing Near 20 SMA
CCI Crossed Below -100 CCI Crossed Below -100

Related Stocks View Details >>

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 216,444.01 900.70 -2.2%
Divi's Laboratories Ltd. 97,676.51 3,670.00 +0.8%
Cipla Ltd. 85,998.13 1,065.65 -0.2%
Dr. Reddy's Laboratories Ltd. 68,714.69 4,127.85 -0.3%
Apollo Hospitals Enterprise Ltd. 61,530.49 4,282.70 -3.1%
Torrent Pharmaceuticals Ltd. 51,200.03 1,512.80 -0.2%
Max Healthcare Institute Ltd. 40,653.72 419.25 -1.8%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-06 55.65 900.70 -2.2%
Divi's Laboratories Ltd. Consolidated 2022-06 31.45 3,670.00 +0.8%
Cipla Ltd. Consolidated 2022-06 34.59 1,065.65 -0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-06 23.00 4,127.85 -0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-06 69.65 4,282.70 -3.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-06 64.10 1,512.80 -0.2%
Max Healthcare Institute Ltd. Consolidated 2022-06 64.55 419.25 -1.8%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-06 4.32 900.70 -2.2%
Divi's Laboratories Ltd. Consolidated 2022-06 7.86 3,670.00 +0.8%
Cipla Ltd. Consolidated 2022-06 4.00 1,065.65 -0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-06 3.40 4,127.85 -0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-06 10.35 4,282.70 -3.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-06 8.03 1,512.80 -0.2%
Max Healthcare Institute Ltd. Consolidated 2022-06 6.33 419.25 -1.8%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.02 900.70 -2.2%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 3,670.00 +0.8%
Cipla Ltd. Consolidated 2022-03 0.04 1,065.65 -0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,127.85 -0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,282.70 -3.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,512.80 -0.2%
Max Healthcare Institute Ltd. Consolidated 2022-03 0.12 419.25 -1.8%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 900.70 -2.2%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,670.00 +0.8%
Cipla Ltd. Consolidated 2022-03 13.10 1,065.65 -0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,127.85 -0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,282.70 -3.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,512.80 -0.2%
Max Healthcare Institute Ltd. Consolidated 2022-03 10.19 419.25 -1.8%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 900.70 -2.2%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,670.00 +0.8%
Cipla Ltd. Consolidated 2022-03 13.10 1,065.65 -0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,127.85 -0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,282.70 -3.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,512.80 -0.2%
Max Healthcare Institute Ltd. Consolidated 2022-03 10.19 419.25 -1.8%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 900.70 -2.2%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 3,670.00 +0.8%
Cipla Ltd. Consolidated 2022-03 21,763.34 1,065.65 -0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,127.85 -0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,282.70 -3.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,512.80 -0.2%
Max Healthcare Institute Ltd. Consolidated 2022-03 3,931.46 419.25 -1.8%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 900.70 -2.2%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 3,670.00 +0.8%
Cipla Ltd. Consolidated 2022-03 2,559.47 1,065.65 -0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,112.20 4,127.85 -0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,282.70 -3.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,512.80 -0.2%
Max Healthcare Institute Ltd. Consolidated 2022-03 605.05 419.25 -1.8%

FAQ's On Eris Lifesciences Ltd.

What is Eris Lifesciences share price?

Can I buy Eris Lifesciences shares now?

What is the Dividend Yield of Eris Lifesciences?

What is the Market Cap of Eris Lifesciences?

What are the key metrics to analyse Eris Lifesciences?

What is the 52 Week High and Low of Eris Lifesciences?

What is the trend of Eris Lifesciences share price?